We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Takeda Products Ireland Ltd

First Floor, 3013 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 642 0021
Fax: +353 1 642 0020
Medical Information Direct Line: 1800 937970
Medical Information e-mail: DSO-UK@takeda.com
Medical Information Facsimile: +44 (0)1628 526 617
Patient Information Leaflet last updated on medicines.ie: 12/01/2018
PIL Condyline Cutaneous Solution 0.5 % w/v

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 12/01/2018 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision
Updated on 10/08/2017 and displayed until 12/01/2018
Reasons for adding or updating:
  • Change to Section 1 - what the product is
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision
  • Improved presentation of PIL
Updated on 27/02/2017 and displayed until 10/08/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision
Updated on 30/09/2016 and displayed until 27/02/2017
Reasons for adding or updating:
  • Change to date of revision
  • Change to marketing authorisation holder
Updated on 14/05/2015 and displayed until 30/09/2016
Reasons for adding or updating:
  • Change to date of revision
  • Addition of information on reporting a side effect.
Updated on 12/06/2014 and displayed until 14/05/2015
Reasons for adding or updating:
  • Change to date of revision
  • Change to marketing authorisation holder
Updated on 18/03/2010 and displayed until 12/06/2014
Reasons for adding or updating:
  • New PIL for medicines.ie
  • PIL Submitted in error

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Podophyllotoxin